ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
8 102,33
0,13%
Dow Jones
39 066,90
-1,52%
DAX
18 691,32
0,05%
Brent Oil
81,085
-0,55%
Bitcoin
67 414,13
-2,44%
Registration Strip Icon for charts Inscrivez-vous pour des graphiques en temps réel, des outils d'analyse et des prix.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Human Genome Sciences, Inc. (MM) (HGSI)

  7. Human Genome Sciences, Inc. (MM) (HGSI) Actualités

HGSI

Human Genome Sciences (HGSI)

Human Genome Sciences, Inc. (MM)
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:HGSI
DateHeureSourceTitreSymboleSociété
03/08/201215h47Edgar (US Regulatory)Amended tender offer statement by Third Party (SC TO-T/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
03/08/201214h52Edgar (US Regulatory)(25-NSE)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
03/08/201209h00Dow Jones NewsGlaxoSmithKline Completes Acquisition of Human Genome SciencesNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201223h29Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201223h23Edgar (US Regulatory)Initial Statement of Beneficial Ownership (3)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201220h24Edgar (US Regulatory)Amended Statement of Changes in Beneficial Ownership (4/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
01/08/201218h55ZacksLoss at HGSI Wider Than Expected - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
31/07/201221h03Edgar (US Regulatory)Amended Statement of Beneficial Ownership (SC 13D/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
30/07/201215h06Dow Jones NewsGlaxoSmithKline Gets 79% Tenders for Human Genome Sciences OfferNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201222h22Edgar (US Regulatory)Quarterly Report (10-Q)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201221h49Edgar (US Regulatory)Amended Statement of Ownership: Solicitation (SC 14D9/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201217h46PR Newswire (US)Securities Lawyers at Goldfarb LLP Seeking More Money, Information for Stockholders of Human Genome Sciences, Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
26/07/201211h45ZacksGlaxo Misses, Guidance Lowered - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
20/07/201215h32Edgar (US Regulatory)Statement of Beneficial Ownership (SC 13D)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
20/07/201201h36Business WireLaw Offices of Howard G. Smith Announces Investigation of Human Genome Sciences Inc. Board of Directors for Potential Breache...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
19/07/201219h44ZacksGlaxo to Increase Stake in Amicus - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
18/07/201203h00PR Newswire (US)Law Office of Brodsky & Smith, LLC Announces Investigation of Human Genome Sciences, Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201223h10Edgar (US Regulatory)Amended Securities Registration (section 12(b)) (8-A12B/A)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201221h05Business WireRyan & Maniskas, LLP Announces Investigation of Human Genome Sciences Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201221h05Business WireHuman Genome Sciences Inc. Board of Directors Under Investigation for Potential Breaches of Fiduciary Duty by Glancy Binkow &...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201220h10ZacksTPG to Acquire Par Pharma for $1.9B - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201218h22Business WireRobbins Umeda LLP Announces an Investigation of Human Genome Sciences, Inc.NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201218h16MarketwiredTraders: Most Active Stocks: (OTCBB: CTDT), (NASDAQ: HGSI), (NASDAQ: AAPL), (NASDAQ: MAT)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201218h12Edgar (US Regulatory)Confidential Treatment Order (CT ORDER)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201218h12ZacksHGSI Accepts Glaxo's $14.25 Bid - Analyst BlogNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
17/07/201216h53Business WireHuman Genome Sciences Shareholder Alert: The Briscoe Law Firm & Powers Taylor, LLP Investigate Sale of Human Genome Sciences ...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
16/07/201223h30Edgar (US Regulatory)Current report filing (8-K)NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
16/07/201218h18Business WireThe Law Firm of Levi & Korsinsky, LLP Announces Investigation into Possible Breaches of Fiduciary Duty by the Board of Human ...NASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
16/07/201215h15Business WireGSK to acquire Human Genome Sciences for US$14.25 per share in cashNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
16/07/201201h10Dow Jones NewsGlaxo Eyes Human Genome Sciences for $2.6 BillionNASDAQ:HGSIHuman Genome Sciences, Inc. (MM)
 Showing the most relevant articles for your search:NASDAQ:HGSI

Dernières Valeurs Consultées

BOV
APER3R
ALPER ON
USOTC
DVVDF
Dividend Select 15 (PK)
EU
VDPCB
Ville de Paris Vdp0.85%0...
COIN
COTDGBP
BIT
P211D2
NLBNPIT211D2 20991231 16...
Delayed Upgrade Clock
ADVFN Logo

France
Société
Entreprise
Popular
Obtenir l'application

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés